This text is a result of machine translation.
In the half year, the 36billion yuan production expansion plan has been thrown away, and the competition in the stock market of Baijiu is fierce
Russian finance minister says West creates artificial obstacles for Russia to repay public debt
The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan
The private placement market is full of chaos, and the regulators' sword is intended to support the good and limit the bad
2022 China AI Health 30 Report
Cro plate fell, and Wuxi apptec fell nearly 10%
The trading limit of AVIC electronics and AVIC electromechanical resumed
The port sector continued to strengthen and Guangzhou port rose by the daily limit
Rhine biology: stephanine belongs to alkaloids. The company has technical reserves for the extraction of similar products
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Tiger medicine: net profit in the first quarter increased by 13.82% year-on-year
Runfeng shares: exchange rate changes have little impact on the company's performance
Deputy Secretary General of China Cement Association: it is expected that the industry will usher in a turnaround in the second quarter
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Mar 31, 2021 11:38 AM
Tesla unveiled a new giant 360mwh Megapack energy storage project
The steel plate rose and Jinling mining rose by the limit
The opening of electronic ID card concept stocks raised the 3-board of Nanwei software
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
WaveFront Ventures: How Can Chinese Companies Win the Global Robotic Race
Mar 24, 2023 02:02 PM
CIRCUE: AI Drives the Revolution of Energy, Leading a Sustainable Future
Mar 23, 2023 12:26 PM
Charging Infrastructure on Government Support: A Brighter Future?
Mar 16, 2023 06:03 PM
Robot Policies in Asia
Mar 10, 2023 10:51 AM